Parexel International Corp. (PRXL) Buy, Sell…

Parexel International Corp. (PRXL)

0.00

-0.00 (0.00%)

1 watching

PAST TOP PICK

(A Top Pick March 23/16. Up 9%.) Does clinical trials for the major drug producers, which is about 75% of their business. It’s been mildly disappointing. A very good company. They are growing their cash, which may lead to a dividend being paid in the near future. Very active in buying back shares. It has lots of potential.

TOP PICK

A contract research organization that basically takes outsourced clinical studies on behalf of pharmaceuticals, runs the studies through various phases on behalf of them. They have $5.4 billion of backlog. Have just gone through a restructuring process which will be additive in the last half of this year to their earnings.

PAST TOP PICK

(A Top Pick April 27/11. Down 2.73%.) Contract research for Pharma companies. Very good company. Now going into partnership with large pharmas.

PAST TOP PICK

(Top Pick Apr 27/11, Down 5.79%) Clinical trial company. It is an efficient model

TOP PICK

Clinical trial management. They take phase 1 drugs and run them through the trials. About a $2.9 billion backlog and a book to bill of about $1.5 billion, meaning that for every $1 they bill, they get orders of $1.50.

PAST TOP PICK

(A Top Pick March 11/09. Up 180.8%.) About 60% of revenues come from outside the US.

PAST TOP PICK

(Top Pick Mar 11/09, Up 163.6%) Not as cheap as it was, but still good value.

TOP PICK

Contract research organization and do drug trials on behalf of pharmaceuticals and biopharmas. Stock has been beaten down on worries of lack of pipeline and foreign exchange worries.

TOP PICK

Contract research that does clinical drug trials for major drug companies. Strong growing franchise.

Showing 1 to 9 of 9 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Parexel International Corp. (PRXL) Frequently Asked Questions

What is Parexel International Corp. stock symbol?

Parexel International Corp. is a OTC stock, trading under the symbol PRXL (previously PRXL-Q on Stockchase) on the undefined (undefined). It is usually referred to as or PRXL

Is Parexel International Corp. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on PRXL (previously PRXL-Q on Stockchase) on Stockchase. Read the latest expert commentary for Parexel International Corp..

Is Parexel International Corp. a good investment or a top pick?

Parexel International Corp. was recommended as a Top Pick by Gordon Reid on 2008-07-09. Read the latest stock experts ratings for Parexel International Corp..

Why is Parexel International Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Parexel International Corp..

Is Parexel International Corp. worth watching?

Parexel International Corp. is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Parexel International Corp. (PRXL)